openPR Logo
Press release

Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis

04-01-2024 02:59 PM CET | Health & Medicine

Press release from: Renub Research

Lung Cancer Diagnostics Market, Size, Global Forecast,

Global lung cancer diagnostics market is projected to attain about US$ 30.84 billion through 2030, as per Renub Research

Lung cancers consequences from uncontrolled cell growth, forming loads referred to as tumors. Typically originating from the lining cells of the airlines (bronchi and bronchioles), it is frequently referred to as bronchogenic cancers or carcinoma. Cigarette smoking is the primary cause, contributing to approximately 90% of instances, at the same time as different factors like lung disease, a prior cancer history, and air pollutants also play a role. Symptoms range depending on tumor location and spread, together with shortness of breath, coughing blood, chest pain, headache, and dysphagia.

Expert Insights: Ask Analyst or Download Full Report with TOC and Figures:

Increasing R&D efforts for early cancer detection are predicted to reinforce the global lung cancer diagnostic market. Researchers at MIT advanced a nanoparticle-primarily-based urine check in April 2020 for early lung cancer detection. This approach detects biomarkers produced by peptide-covered nanoparticles interacting with tumor-associated proteases. Validated in two mouse models, the test identified tumors as small as 2.18 mm. Its noninvasive nature reduces false positives from conventional tests, enhancing early tumor detection.

The global lung cancer diagnostics market reached US$ 18.2 Billion in 2023 and is projected to develop at a CAGR of 7.23% from 2024 to 2030. Increasing lung cancer rates, driven by lifestyle shifts and heightened tobacco use, will raise the demand for surgical devices, fostering a boom in the lung cancer diagnostic market. Lifestyle choices, like smoking, once symbolic of freedom, now pose subnational health risks. Smoking and dietary and exercise behaviors contribute to this complicated issue. Its vast prevalence poses a widespread public heath venture and is a primary cause of lung cancer. The surge in tobacco intake, shaped by evolving lifestyles, is anticipated to propel market growth. In May 2022, according to a WHO, tobacco claims over 8 million lives annually, with 7 million from direct use and 1.2 million from secondhand smoke.

Request a free sample copy of the report:

Imaging tests represent one of the leading segments within the global lung cancer diagnostics market.

Imaging tests are at the forefront of the global lung cancer diagnostics market, pivotal in early detection, diagnosis, and disease monitoring. These tests, which include chest X-rays, computed tomography (C.T.) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, provide detailed images of the lungs, allowing healthcare professionals to identify abnormalities such as tumors or nodules. With advancements in imaging technology and increased accessibility to these tests, they have become indispensable tools in the fight against lung cancer, facilitating timely intervention and improving patient outcomes in the ever-evolving landscape of cancer diagnosis and treatment.

Non-Small Cell Lung Cancer (NSCLC) occupies a significant position within the global lung cancer diagnostics market.

Non-Small Cell Lung Cancer (NSCLC) is one of the most significant components in the global lung cancer diagnostics market. As the most common type of lung cancer, NSCLC comprises various subtypes, each requiring precise diagnostic approaches for effective management. Diagnostic methods such as imaging tests, molecular testing, and biopsies are crucial in accurately identifying NSCLC and determining optimal treatment strategies tailored to individual patients. With advancements in diagnostic technologies and therapies, addressing NSCLC holds paramount importance in improving patient outcomes and reducing the burden of lung cancer worldwide, positioning it as a key focus area in the ongoing evolution of lung cancer diagnostics.

Hospital-associated hospital laboratories are extensively utilized in the global lung cancer diagnostics market.

Hospital-associated labs play a pivotal role in the global lung cancer diagnostics market. These facilities are essential hubs for conducting various diagnostic tests, including imaging studies, molecular analyses, and tissue biopsies, which are crucial for accurately detecting and characterizing lung cancer. Their close integration with clinical care settings enables swift sample processing and timely reporting of results, facilitating prompt treatment decisions and patient management. As key contributors to the diagnostic pathway, hospital-associated labs significantly improve patient outcomes and advance research efforts in the ongoing fight against lung cancer, underscoring their integral role in the healthcare ecosystem.

The United States could maintain its dominance in the global lung cancer diagnostics market.

The United States is poised to uphold its leading position in the global lung cancer diagnostics market. Renowned for its advanced healthcare infrastructure, the U.S. boasts cutting-edge diagnostic technologies and widespread access to screening and testing services. Additionally, the country's robust research and development efforts and substantial investments in cancer research further solidify its dominance. With a focus on innovation and a commitment to improving diagnostic accuracy and patient outcomes, the United States is positioned to sustain its leadership in lung cancer diagnostics, driving advancements that benefit patients worldwide.

Key Players

The global market for lung cancer diagnostics includes prominent firms such as Illumina, Abbott Laboratories, Thermo Fisher Scientific, Inc., QIAGEN N.V., Roche Holding AG, Sanofi S.A., Agilent Technologies, and bioMérieux.

Related Reports

Lung Cancer Screening Market:
Global Teleradiology Market:
Non-Small Cell Lung Cancer Market:
Molecular Diagnostics Market:

Diagnosis Test Type - Market breakup in 5 viewpoints:

1. Imaging Test
2. Biopsy
3. Sputum Cytology
4. Molecular Test
5. Others

Cancer Type - Market breakup in 2 viewpoints:

1. Non- Small Cell Lung Cancer
2. Small Cell Lung Cancer

End-User - Market breakup in 5 viewpoints:

1. Hospital Associated Labs
2. Independent Diagnostic Laboratories
3. Diagnostic Imaging Centers
4. Cancer Research Institutes
5. Others

Country - Market breakup in 25 Countries:

1. North America
1.1 United States
1.2 Canada

2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue Analysis
Company Analysis:
1. llumina
2. Abbott Laboratories
3. Thermo Fisher Scientific, Inc.
5. Roche Holding AG.
6. Sanofi S.A.
7. Agilent Technologies
8. bioMérieux.

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis here

News-ID: 3447899 • Views:

More Releases from Renub Research

Global Chocolate Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Global Chocolate Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) …
Global Chocolate Market Size was US$132.65 billion in 2023 and is expected to reach to US$196.79 billion by 2032. It is predicted to expend at a CAGR of 4.48% from 2024 to 2032. Chocolate is a beloved treat worldwide and has been for hundreds of years. The worldwide chocolate industry is worth billions of dollars, and new trends are continuously emerging. Chocolate liquor and cocoa cream are used to make
Global Automotive Air Suspension Market, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Global Automotive Air Suspension Market, Size, Share, Growth ⅼ Forecast (2024 …
Global Automotive Air Suspension Market value is expected to be about US$ 11.20 Billion by 2032. The CAGR for the automotive air suspension market from 2024 to 2032 is 6.05%. Renub Research stated that it was valued at US$ 6.60 Billion in 2023. During World War II, the US developed an air suspension system, especially for heavier aircraft. Air suspension was first developed as a lightweight, compact construction method. A vehicle
Saudi Arabia Chocolate Market Size, Share, Growth ⅼ Forecast (2024 -2032) ⅼ Renub Research
Saudi Arabia Chocolate Market Size, Share, Growth ⅼ Forecast (2024 -2032) ⅼ …
Saudi Arabia chocolate market was US$ 1,0.5.68 Million in 2023 and it is projected to reach US$ 1,585.03 Million by 2032 with a CAGR of 4.73% from 2024 to 2032. The intake of goodies in Saudi Arabia reflects changing market tends and evolving cultural values. Saudi Arabia boasts of being the largest market for chocolates, and its annual consumption has been increasing at a rate of 5.5%, indicating its developing
Saudi Arabia Contact Lenses Market Analysis, Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Saudi Arabia Contact Lenses Market Analysis, Size, Share, Growth ⅼ Forecast (2 …
According to Renub Research, Saudi Arabia contact lens market was worth US$115.79 Million in 2023 and is anticipated to reach US$ 212.88 Million by 2032, developing at a CAGR of 7% from 2024 to 2032. The Saudi Arabian contact lens market is increasing because of the rising occurrence of ocular diseases, increasing awareness about the blessings of contact lenses, and the desire for daily disposable lenses. The market is regulated to

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top